Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
140.80B
Market cap140.80B
Price-Earnings ratio
37.87
Price-Earnings ratio37.87
Dividend yield
0.73%
Dividend yield0.73%
Average volume
3.86M
Average volume3.86M
High today
$199.84
High today$199.84
Low today
$195.05
Low today$195.05
Open price
$197.38
Open price$197.38
Volume
3.81M
Volume3.81M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$160.93
52 Week low$160.93

Stock Snapshot

The current Danaher(DHR) stock price is $199.05, with a market capitalization of 140.8B. The stock trades at a price-to-earnings (P/E) ratio of 37.87 and offers a dividend yield of 0.73%.

On 2026-07-10, Danaher(DHR) stock moved within a range of $195.05 to $199.84. With shares now at $199.05, the stock is trading +2.1% above its intraday low and -0.4% below the session's peak.

Trading activity shows a volume of 3.81M, compared to an average daily volume of 3.86M.

The stock's 52-week range extends from a low of $160.93 to a high of $242.80.

The stock's 52-week range extends from a low of $160.93 to a high of $242.80.

DHR News

Simply Wall St 3d
What Danaher's New p-Tau217 Alzheimer’s Assays Mean For Shareholders

Danaher’s Beckman Coulter Diagnostics unit has secured a CE Mark under IVDR for its Access p-Tau217 blood assay and introduced a high-specificity BD-pTau217 res...

What Danaher's New p-Tau217 Alzheimer’s Assays Mean For Shareholders
TipRanks 5d
Danaher price target lowered to $230 from $232 at Evercore ISI

Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Danaher (DHR) to $230 from $232 and keeps an Outperform rating on the shares. The firm’s Q2...

Analyst ratings

86%

of 29 ratings
Buy
86.2%
Hold
13.8%
Sell
0%

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.